EUVIMEDEUVIMED entdecken
Crossref

NORAD Overexpression Enhances hiPSC-CM Regenerative Potency via PUM2/ MASTL Signaling

Kanghui Huan iD, Yujian Jiang iD, Xin Xie, Weifeng Xu iD, Xiaolei Duan iD, Sai Yao iD, Yanli Cheng iD, Shaomeng Li iD, Yanfang Duan iD, Yingxin Yuan iD, Yeying Sun, Meng Zhao iD und 1 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026-08 · 46 (8)

DOI: 10.1161/atvbaha.126.324431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026-08. Verfasst von Kanghui Huan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Binzhou Medical University Hospital, Binzhou Medical University, China (K.H., X.X., Y.C., W.B.). Hauptthemen laut MEDLINE: Myocytes, Cardiac, Myocardial Infarction, Induced Pluripotent Stem Cells, Regeneration. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The engraftment of induced cells from human pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) for myocardial infarction therapy is critically hindered by their low cell-cycle activity and survival rates. In this study, we explored the role of the long noncoding RNA activated by DNA damage ( NORAD ) in enhancing the cell-cycle activity and engraftment of hiPSC-CMs, providing new insights into myocardial repair. METHODS: hiPSC-CMs overexpressing NORAD (hiPSC- NORAD OE CMs) were generated via lentiviral transduction using a cardiac-specific promoter, whereas NORAD knockdown was achieved by small interfering RNA transfection. The effects of NORAD on cell-cycle activity, nuclear DNA content, nuclear number, maturation, and apoptosis in hiPSC-CMs were examined in vitro using Western blot, reverse transcription quantitative polymerase chain reaction, immunofluorescence, and flow cytometry. In a murine myocardial infarction model, hiPSC-CMs overexpressing NORAD were transplanted into the infarcted myocardium. Engraftment, cell-cycle activity, and infarct size were evaluated by immunofluorescence, and cardiac function was assessed by echocardiography. Furthermore, the molecular mechanisms underlying NORAD -mediated regulation of hiPSC-CM cell-cycle activity were investigated, including its role in exosome-mediated paracrine effects on host cardiomyocytes. RESULTS: NORAD overexpression significantly increased the percentages of Ki67 (antigen KI-67)-positive, PH3 (phosphorylated histone 3)-positive, Aurora B–positive, and EdU (5-ethynyl-2’-deoxyuridine)-positive cells. It also increased the proportion of diploid nuclei and mononucleated cells, induced a trend toward a less mature state, and reduced apoptosis in hiPSC-CMs. Transplantation of hiPSC-CMs overexpressing NORAD improved myocardial repair, with greater cell-cycle activity of engrafted cells and endogenous cardiomyocytes in the myocardial infarction model. Mechanistically, NORAD exerted its effects by sequestering PUM2 (pumilio RNA-binding protein family member 2), an RNA-binding protein, thereby alleviating its translational repression of MASTL (microtubule-associated serine/threonine kinase like), a key regulator of mitotic progression. Moreover, exosomes secreted by hiPSC-CMs overexpressing NORAD promoted the cell-cycle activity of recipient cardiomyocytes, suggesting a possible paracrine contribution to myocardial repair. CONCLUSIONS: NORAD overexpression promoted cell-cycle progression via the PUM2/ MASTL mRNA axis. Moreover, exosomes derived from these cells stimulated endogenous cardiomyocyte cell-cycle activity, contributing to myocardial repair. These findings underscore the therapeutic potential of NORAD -modulated hiPSC-CMs for promoting myocardial repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacMyocardial InfarctionInduced Pluripotent Stem CellsRegenerationRNA-Binding ProteinsAnimalsHumansSignal TransductionDisease Models, AnimalExosomesApoptosisParacrine CommunicationCell CycleCells, CulturedCell ProliferationMice, Inbred C57BLMaleCell DifferentiationVentricular Function, LeftTransfectionMice

Stichwörter der Autor:innen

apoptosisexosomesinfarctionmyocardial infarctiontransfection

Substanzen

RNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Cardiology, Binzhou Medical University Hospital, Binzhou Medical University, China (K.H., X.X., Y.C., W.B.).
  • Department of Pharmacy, Binzhou Medical University, Yantai, China (K.H., Y.J., W.X., X.D., S.L., Y.D., Y.Y., Y.S., W.B.).
  • Frontier Innovation Center, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, China (K.H., S.Y., M.Z.).
  • Shandong Provincial Engineering Research Center for Probiotic Functional Nutrition and Special Medical Foods, Yantai, China (W.B.).

ORCID-Profile: Kanghui Huan, Yujian Jiang, Weifeng Xu, Xiaolei Duan, Sai Yao, Yanli Cheng, Shaomeng Li, Yanfang Duan, Yingxin Yuan, Meng Zhao, Weihua Bian

Zitieren

APA

Huan, K., Jiang, Y., Xie, X., Xu, W., Duan, X., Yao, S., Cheng, Y., Li, S., Duan, Y., Yuan, Y., Sun, Y., Zhao, M., & Bian, W. (2026). NORAD Overexpression Enhances hiPSC-CM Regenerative Potency via PUM2/ MASTL Signaling. Arteriosclerosis, Thrombosis, and Vascular Biology, 46(8). https://doi.org/10.1161/atvbaha.126.324431

Vancouver

Huan K, Jiang Y, Xie X, Xu W, Duan X, Yao S, et al. NORAD Overexpression Enhances hiPSC-CM Regenerative Potency via PUM2/ MASTL Signaling. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026;46(8). doi:10.1161/atvbaha.126.324431

BibTeX
@article{Huan2026,
  author = {Huan, Kanghui and Jiang, Yujian and Xie, Xin and Xu, Weifeng and Duan, Xiaolei and Yao, Sai and Cheng, Yanli and Li, Shaomeng and Duan, Yanfang and Yuan, Yingxin and Sun, Yeying and Zhao, Meng and Bian, Weihua},
  title = {NORAD Overexpression Enhances hiPSC-CM Regenerative Potency via PUM2/ MASTL Signaling},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  volume = {46},
  number = {8},
  doi = {10.1161/atvbaha.126.324431}
}
Kostenlos starten →